Flosonics Medical nominated for Best Medical Technology for the 2023 Prix Galien USA Awards

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, recently announced the 2023 Prix Galien USA Award nominees for different categories. Winners will be announced during the Prix Galien USA Forum on October 26 in New York City.

Congratulations to Flosonics Medical, an OBIO® member and an alumnus of all OBIO® programs, on being nominated in the 'Best Medical Technology' category, and to other nominees.

Previous
Previous

Empower Health among 12 companies in the cohort of artificial intelligence ventures solving supply chain challenges

Next
Next

OBIO® member companies among top ten Canadian tech firms to pitch innovative healthcare solutions